文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症心脑血管急症

创伤性脑损伤患者的急性肾损伤:欧洲神经创伤协作研究结果

Acute Kidney Injury in Traumatic Brain Injury Patients: Results From the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论创伤性脑损伤后急性肾损伤发生早(中位2天)、约每10例中1例,与6个月死亡及神经功能不良结局相关;渗透治疗可能是可干预危险因素。

该多中心前瞻性观察性纵向队列研究纳入欧洲65个ICU中ICU停留超过72小时且有至少两次血清肌酐值的创伤性脑损伤患者,最终分析1262例。按肾脏病改善全球结局标准分期,第一周急性肾损伤总发生率约12%:1期8%(n=100)、2期1%(n=14)、3期3%(n=36),中位发生时间为入ICU后2天(四分位距1-4天)。肾病史、胰岛素依赖型糖尿病、高钠血症及渗透治疗与急性肾损伤风险独立相关。急性肾损伤与ICU停留时间延长、6个月扩展格拉斯哥结局量表不良及死亡率升高相关。

要点

  • 创伤性脑损伤后急性肾损伤多发生在入ICU早期,中位2天(四分位距1-4天),第一周总发生率约12%。
  • 第一周急性肾损伤分期发生率:1期8%(n=100)、2期1%(n=14)、3期3%(n=36)。
  • 肾病史(HR 2.48;95%CI 1.39-4.43;p=0.002)、胰岛素依赖型糖尿病(HR 2.52;95%CI 1.22-5.197;p=0.012)、高钠血症(HR 1.88;95%CI 1.31-2.71;p=0.001)及渗透治疗(HR 2.08;95%CI 1.45-2.99;p<0.001)与急性肾损伤风险显著相关。
  • 急性肾损伤与ICU停留时间延长、6个月扩展格拉斯哥结局量表不良概率升高及死亡率升高相关。

适用人群与场景

  • 欧洲65个ICU中创伤性脑损伤患者,ICU停留时间大于72小时且入ICU前7天内至少有两次血清肌酐值者纳入分析。

诊断标准与关键阈值

  • 采用肾脏病改善全球结局标准将急性肾损伤分为三期:1期为血清肌酐升至基线1.5-1.9倍或48小时内升高大于或等于0.3 mg/dL;2期为血清肌酐升至基线2-2.9倍;3期为血清肌酐升至基线3倍或大于或等于4 mg/dL或需要肾脏替代治疗。

研究设计与关键结果

  • 研究类型为多中心前瞻性观察性纵向队列研究,纳入欧洲65个ICU的创伤性脑损伤患者,最终分析1262例。
  • 主要终点第一周急性肾损伤发生率:1期8%(n=100)、2期1%(n=14)、3期3%(n=36)。
  • 急性肾损伤发生时机:中位2天(四分位距1-4天)。
  • 多变量Cox回归显示与急性肾损伤发生相关的因素:肾病史(HR 2.48;95%CI 1.39-4.43;p=0.002)、胰岛素依赖型糖尿病(HR 2.52;95%CI 1.22-5.197;p=0.012)、高钠血症(HR 1.88;95%CI 1.31-2.71;p=0.001)、渗透治疗(HR 2.08;95%CI 1.45-2.99;p<0.001)。
  • 急性肾损伤与ICU停留时间延长、6个月扩展格拉斯哥结局量表不良概率升高及死亡率升高相关。

证据类型、等级与局限

  • 证据类型:多中心前瞻性观察性纵向队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 创伤性脑损伤患者入ICU早期(中位2天)应关注急性肾损伤发生,约每10例中1例发生急性肾损伤。
  • 肾病史、胰岛素依赖型糖尿病、高钠血症及渗透治疗使用与急性肾损伤风险升高相关,其中渗透治疗可能是可干预的危险因素(作者认为)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Acute kidney injury is frequent in polytrauma patients, and it is associated with increased mortality and extended hospital length of stay. However, the specific prevalence of acute kidney injury after traumatic brain injury is less recognized. The present study aims to describe the occurrence rate, risk factors, timing, and association with outcome of acute kidney injury in a large cohort of traumatic brain injury patients.

DESIGN: The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury is a multicenter, prospective observational, longitudinal, cohort study.

SETTING: Sixty-five ICUs across Europe.

PATIENTS: For the present study, we selected 4,509 traumatic brain injury patients with an ICU length of stay greater than 72 hours and with at least two serum creatinine values during the first 7 days of ICU stay.

MEASUREMENTS AND MAIN RESULTS: We classified acute kidney injury in three stages according to the Kidney Disease Improving Global Outcome criteria: acute kidney injury stage 1 equals to serum creatinine × 1.5-1.9 times from baseline or an increase greater than or equal to 0.3 mg/dL in 48 hours; acute kidney injury stage 2 equals to serum creatinine × 2-2.9 times baseline; acute kidney injury stage 3 equals to serum creatinine × three times baseline or greater than or equal to 4 mg/dL or need for renal replacement therapy. Standard reporting techniques were used to report incidences. A multivariable Cox regression analysis was performed to model the cause-specific hazard of acute kidney injury and its association with the long-term outcome. We included a total of 1,262 patients. The occurrence rate of acute kidney injury during the first week was as follows: acute kidney injury stage 1 equals to 8% (n = 100), acute kidney injury stage 2 equals to 1% (n = 14), and acute kidney injury stage 3 equals to 3% (n = 36). Acute kidney injury occurred early after ICU admission, with a median of 2 days (interquartile range 1-4 d). Renal history (hazard ratio = 2.48; 95% CI, 1.39-4.43; p = 0.002), insulin-dependent diabetes (hazard ratio = 2.52; 95% CI, 1.22-5.197; p = 0.012), hypernatremia (hazard ratio = 1.88; 95% CI, 1.31-2.71; p = 0.001), and osmotic therapy administration (hazard ratio = 2.08; 95% CI, 1.45-2.99; p < 0.001) were significantly associated with the risk of developing acute kidney injury. Acute kidney injury was also associated with an increased ICU length of stay and with a higher probability of 6 months unfavorable Extended Glasgow Outcome Scale and mortality.

CONCLUSIONS: Acute kidney injury after traumatic brain injury is an early phenomenon, affecting about one in 10 patients. Its occurrence negatively impacts mortality and neurologic outcome at 6 months. Osmotic therapy use during ICU stay could be a modifiable risk factor.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Robba C, Banzato E, Rebora P, et al. Acute Kidney Injury in Traumatic Brain Injury Patients: Results From the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study. Crit Care Med. 2021. PMID: 33060506. doi:10.1097/CCM.0000000000004673

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。